{"id":24231,"date":"2024-05-07T14:34:14","date_gmt":"2024-05-07T12:34:14","guid":{"rendered":"https:\/\/ggba.swiss\/machinemd-and-gaitq-awarded-grant-for-parkinsons-research-in-the-uk-and-switzerland\/"},"modified":"2024-05-07T14:42:34","modified_gmt":"2024-05-07T12:42:34","slug":"machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/","title":{"rendered":"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.machinemd.com\/\">machineMD<\/a>, reconnue pour son approche innovante en neuro-ophtalmologie, et <a href=\"https:\/\/www.gaitq.com\/\">gaitQ<\/a>, sp\u00e9cialis\u00e9e dans les solutions de mobilit\u00e9, collaboreront pour collecter et analyser les donn\u00e9es relatives \u00e0 la mobilit\u00e9 et aux mouvements oculaires. Ces donn\u00e9es permettront d&rsquo;\u00e9tablir des sch\u00e9mas comportementaux et fourniront aux cliniciens des indications pour \u00e9laborer des plans de traitement plus efficaces, ce qui pourrait conduire \u00e0 un diagnostic plus pr\u00e9coce et \u00e0 une meilleure prise en charge des patients.<\/p>\n\n\n\n<p>Les recherches seront men\u00e9es \u00e0 l&rsquo;universit\u00e9 d&rsquo;Exeter et \u00e0 l&rsquo;h\u00f4pital universitaire de Zurich et se concentreront sur le suivi de la progression de la maladie de Parkinson, une affection qui touche plus de 10 millions de personnes dans le monde et dont le nombre devrait doubler d&rsquo;ici \u00e0 2030. \u00ab Cette recherche identifie les moments cl\u00e9s de la progression de la maladie et vise \u00e0 mieux en comprendre les causes et les raisons \u00bb, a d\u00e9clar\u00e9 le Dr Tristan Collins, CEO de gaitQ. \u00ab Cela peut aider les cliniciens et les physioth\u00e9rapeutes sp\u00e9cialis\u00e9s \u00e0 cr\u00e9er des plans de traitement plus pertinents et personnalis\u00e9s. \u00bb<\/p>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Western Switzerland for Medtech Companies (machineMD)\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/KH4vBkQPXng?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>Ana Coito, neuroscientifique chez machineMD, a soulign\u00e9 l&rsquo;importance d&rsquo;un diagnostic pr\u00e9coce et pr\u00e9cis. \u00ab Les personnes atteintes de la maladie de Parkinson peuvent rester asymptomatiques jusqu&rsquo;\u00e0 ce que 50 \u00e0 60 % des neurones dopaminergiques aient disparu \u00bb, a-t-elle expliqu\u00e9. Le projet vise \u00e0 utiliser les fonctions oculo-motrices anormales, pr\u00e9sentes chez 75 \u00e0 87,5 % des patients atteints de la maladie de Parkinson, afin d&rsquo;identifier des biomarqueurs num\u00e9riques pr\u00e9cieux pour un suivi plus pr\u00e9cis de la maladie.<\/p>\n\n\n\n<p>Ce projet de collaboration entre machineMD et gaitQ repr\u00e9sente une avanc\u00e9e majeure dans la lutte contre la maladie de Parkinson, en combinant l&rsquo;expertise des deux entreprises afin de d\u00e9gager de nouvelles perspectives pour am\u00e9liorer les traitements et les soins aux patients.<\/p>\n\n\n\n<p><strong>Un \u00e9cosyst\u00e8me de soutien important pour les entreprises de technologie m\u00e9dicale<\/strong><\/p>\n\n\n\n<p>Forte de ses succ\u00e8s, machineMD a constamment d\u00e9montr\u00e9 son potentiel et ses capacit\u00e9s d&rsquo;innovation au sein de <a href=\"https:\/\/ggba.swiss\/fr\/lecosysteme-des-start-ups-dans-le-canton-de-berne\/\">l&rsquo;\u00e9cosyst\u00e8me bernois des start-ups<\/a>. Le soutien d&rsquo;entit\u00e9s telles que le <a href=\"https:\/\/www.ssc.swiss\/\">Sitem Startup Club<\/a> a jou\u00e9 un r\u00f4le d\u00e9terminant dans la croissance de machineMD, en lui fournissant non seulement un espace physique, mais aussi une communaut\u00e9 riche en ressources, en mentorat et en possibilit\u00e9s de mise en r\u00e9seau. Cet environnement stimulant a permis \u00e0 machineMD de prosp\u00e9rer, ce qui l&rsquo;a amen\u00e9 \u00e0 passer \u00e0 la <a href=\"https:\/\/ggba.swiss\/fr\/machinemd-rejoint-les-cinq-finalistes-de-la-deuxieme-phase-de-laccelerateur-dayone-health-4-0\/\">deuxi\u00e8me phase de l&rsquo;acc\u00e9l\u00e9rateur DayOne Health 4.0<\/a> et \u00e0 <a href=\"https:\/\/ggba.swiss\/fr\/machinemd-start-up-issue-du-sitem-startup-club-leve-chf-32-millions\/\">obtenir d&rsquo;importants financements<\/a>.<\/p>\n\n\n\n<p>Ces r\u00e9alisations refl\u00e8tent non seulement l&rsquo;engagement de machineMD \u00e0 faire progresser la technologie m\u00e9dicale, mais aussi la force du syst\u00e8me de soutien que Berne offre aux jeunes entreprises d\u00e9sireuses d&rsquo;avoir un impact global sur les soins de sant\u00e9.<\/p>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Sitem Startup Club  (What Is Series)\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/nder9nGNNGo?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 medtech bernoise machineMD et gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d&rsquo;un million de dollars d&rsquo;InnovateUK et d&rsquo;Innosuisse pour am\u00e9liorer le suivi et la d\u00e9tection pr\u00e9coce de la maladie de Parkinson.<\/p>\n","protected":false},"author":6,"featured_media":24228,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1148,1218,1163,1141,1158],"class_list":["post-24231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-financing-fr-2","tag-incubator-fr-2","tag-medtech-fr-2","tag-personalized-medicine-fr-2","tag-virtual-reality-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson<\/title>\n<meta name=\"description\" content=\"machineMD et la gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d&#039;un million de dollars d&#039;InnovateUK et d&#039;Innosuisse.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson\" \/>\n<meta property=\"og:description\" content=\"machineMD et la gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d&#039;un million de dollars d&#039;InnovateUK et d&#039;Innosuisse.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-07T12:34:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-07T12:42:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease-1024x704.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"704\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson\",\"datePublished\":\"2024-05-07T12:34:14+00:00\",\"dateModified\":\"2024-05-07T12:42:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\"},\"wordCount\":493,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Financing\",\"Incubator\",\"Medtech\",\"Personalized Medicine\",\"Virtual Reality\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\",\"name\":\"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg\",\"datePublished\":\"2024-05-07T12:34:14+00:00\",\"dateModified\":\"2024-05-07T12:42:34+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"machineMD et la gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d'un million de dollars d'InnovateUK et d'Innosuisse.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg\",\"width\":2360,\"height\":1622,\"caption\":\"Cette bourse soutiendra un projet de recherche de 18 mois visant \u00e0 enregistrer les biomarqueurs num\u00e9riques de 100 personnes atteintes de la maladie de Parkinson au Royaume-Uni et en Suisse, \u00e0 l'occasion de la Journ\u00e9e mondiale de la maladie de Parkinson.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson","description":"machineMD et la gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d'un million de dollars d'InnovateUK et d'Innosuisse.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/","og_locale":"fr_FR","og_type":"article","og_title":"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson","og_description":"machineMD et la gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d'un million de dollars d'InnovateUK et d'Innosuisse.","og_url":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-05-07T12:34:14+00:00","article_modified_time":"2024-05-07T12:42:34+00:00","og_image":[{"width":1024,"height":704,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease-1024x704.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson","datePublished":"2024-05-07T12:34:14+00:00","dateModified":"2024-05-07T12:42:34+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/"},"wordCount":493,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg","keywords":["Artificial Intelligence","Financing","Incubator","Medtech","Personalized Medicine","Virtual Reality"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/","url":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/","name":"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg","datePublished":"2024-05-07T12:34:14+00:00","dateModified":"2024-05-07T12:42:34+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"machineMD et la gaitQ, bas\u00e9e \u00e0 Oxford, ont re\u00e7u conjointement une bourse de recherche d'un million de dollars d'InnovateUK et d'Innosuisse.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/machinemd-parkinsons-disease.jpeg","width":2360,"height":1622,"caption":"Cette bourse soutiendra un projet de recherche de 18 mois visant \u00e0 enregistrer les biomarqueurs num\u00e9riques de 100 personnes atteintes de la maladie de Parkinson au Royaume-Uni et en Suisse, \u00e0 l'occasion de la Journ\u00e9e mondiale de la maladie de Parkinson."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/machinemd-et-gaitq-recoivent-une-bourse-pour-la-recherche-sur-la-maladie-de-parkinson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"MachineMD et gaitQ re\u00e7oivent une bourse pour la recherche sur la maladie de Parkinson"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=24231"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24231\/revisions"}],"predecessor-version":[{"id":24233,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24231\/revisions\/24233"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/24228"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=24231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=24231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=24231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}